|4.69||-0.0700||-1.47%||Vol 607.70K||1Y Perf 16.38%|
|Feb 3rd, 2023 16:00 DELAYED|
|- -||-0.04 -0.85%|
|Target Price||7.14||Analyst Rating||Strong Buy 1.29|
|Potential %||52.24||Finscreener Ranking||★★+ 47.37|
|Insiders Trans % 3/6/12 mo.||100/100/100||Value Ranking||★+ 43.03|
|Insiders Value % 3/6/12 mo.||100/100/100||Growth Ranking||★ 38.31|
|Insiders Shares Cnt. % 3/6/12 mo.||100/100/100||Income Ranking||— -|
|Price Range Ratio 52W %||89.49||Earnings Rating||Strong Sell|
|Market Cap||850.84M||Earnings Date||27th Feb 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||27th Feb 2023|
|Estimated EPS Next Report||-0.16|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||976.23K|
|Avg. Monthly Volume||1.08M|
|Avg. Quarterly Volume||778.18K|
ViewRay Inc. (NASDAQ: VRAY) stock closed at 4.69 per share at the end of the most recent trading day (a -1.47% change compared to the prior day closing price) with a volume of 607.70K shares and market capitalization of 850.84M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 309 people. ViewRay Inc. CEO is Scott W. Drake.
The one-year performance of ViewRay Inc. stock is 16.38%, while year-to-date (YTD) performance is 4.69%. VRAY stock has a five-year performance of -45.78%. Its 52-week range is between 2.39 and 4.96, which gives VRAY stock a 52-week price range ratio of 89.49%
ViewRay Inc. currently has a PE ratio of -8.10, a price-to-book (PB) ratio of 8.28, a price-to-sale (PS) ratio of 12.39, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -44.36%, a ROC of -57.81% and a ROE of -104.49%. The company’s profit margin is -%, its EBITDA margin is -111.10%, and its revenue ttm is $67.52 Million , which makes it $0.37 revenue per share.
Of the last four earnings reports from ViewRay Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.16 for the next earnings report. ViewRay Inc.’s next earnings report date is 27th Feb 2023.
The consensus rating of Wall Street analysts for ViewRay Inc. is Strong Buy (1.29), with a target price of $7.14, which is +52.24% compared to the current price. The earnings rating for ViewRay Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
ViewRay Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
ViewRay Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.71, ATR14 : 0.20, CCI20 : 49.86, Chaikin Money Flow : 0.16, MACD : 0.03, Money Flow Index : 55.47, ROC : 0.64, RSI : 53.79, STOCH (14,3) : 59.00, STOCH RSI : 0.77, UO : 50.31, Williams %R : -41.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of ViewRay Inc. in the last 12-months were: B. Kristine Johnson (Buy at a value of $112 704), Brian K. Roberts (Buy at a value of $47 680), Caley Castelein (Buy at a value of $3 601 119), Daniel Jeffrey Moore (Buy at a value of $250 001), Karen N. Prange (Buy at a value of $100 002), Scott W. Drake (Buy at a value of $399 994), Susan C. Schnabel (Buy at a value of $300 930), Zachary William Stassen (Buy at a value of $318 250)
Thu, 05 Jan 2023 13:50 GMT Analysts Offer Insights on Healthcare Companies: Viewray (VRAY) and IN8bio (INAB)- TipRanks. All rights reserved.
Wed, 07 Sep 2022 11:55 GMT Viewray (VRAY) Receives a Buy from BTIG- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.